1 April 2025 false No description of principal activity Taxfiler 2024.6 15545363 business:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15545363 2025-03-31 15545363 2025-04-01 2026-03-31 15545363 business:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 15545363 business:FilletedAccounts 2025-04-01 2026-03-31 15545363 2026-03-31 15545363 business:Director1 2025-04-01 2026-03-31 15545363 business:RegisteredOffice 2025-04-01 2026-03-31 15545363 2025-03-31 15545363 core:WithinOneYear 2026-03-31 15545363 core:WithinOneYear 2025-03-31 15545363 countries:EnglandWales 2025-04-01 2026-03-31 15545363 2024-03-07 2025-03-31 15545363 business:Micro-entities 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure
Company Registration No. 15545363 (England and Wales)
Pharmasync Limited Unaudited accounts for the year ended 31 March 2026
Pharmasync Limited Annual report and unaudited accounts for the year ended 31 March 2026
CONTENTS
PAGE
Company information
3
Statement of financial position
4
- 2 -
Pharmasync Limited Company Information for the year ended 31 March 2026
Director
Wael Sayed
Company Number
15545363 (England and Wales)
Registered Office
17 Cromwell Avenue Gatley Cheadle Cheshire SK8 4BS England
- 3 -
Pharmasync Limited Statement of Financial Position as at 31 March 2026
2026
2025
£
£
Current assets
10,622
13,219
Creditors: amounts falling due within one year
(10,622)
(13,138)
Net current assets
-
81
Total assets less current liabilities
-
81
Net assets
-
81
Capital and reserves
-
81
NOTES TO THE ACCOUNTS
1 Statutory information
Pharmasync Limited is a private company, limited by shares, registered in England and Wales, registration number 15545363. The registered office is 17 Cromwell Avenue, Gatley, Cheadle, Cheshire, SK8 4BS, England.
2 Average number of employees
During the year the average number of employees was 2 (2025: 1).
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 17 March 2026
Wael Sayed Director Company Registration No. 15545363
- 4 -